USC Norris
>
Clinical Trials
Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
IRB
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
» Contact Us
» Glossary
If you are a patient, please contact
Keck Medical Center of USC
at 800-USC-CARE.
Trial 7H-17-2
A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (MK3475-689) (Keynote 689) (LA HNSCC)
Type:
Treatment
Phase:
Phase III
Status:
Open to Accrual
Treatments:
Chemotherapy: Systemic, Immunotherapy
Randomized:
Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Jorge Nieva, M.D.
Other Trial Staff:
Victoria Amran, D.M., Grace Facio, Coordinator, Gina Tse, Coordinator, Eduardo Mejia, D.M., Laurie De Oliveira, Coordinator
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.